Inhibitors of metalloprotease, γ-sectretase, protein kinase C and Rho kinase inhibit wild-type adenoviral replication.
Adenoviruses cause upper respiratory infections, conjunctivitis, keratitis, and gastrointestinal illness. These can be fatal in immunocompromised individuals. Adenoviruses have also been engineered into viral vectors to deliver therapeutic genes or induce immunity as vaccine carriers. The success of...
Main Authors: | Alice Liu, Cristhian J Ildefonso, Wesley S Bond, Mary Y Hurwitz, Richard L Hurwitz |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0236175 |
Similar Items
-
Rho-kinase inhibitors in ophthalmology
by: Megha Gopalakrishna, et al.
Published: (2021-01-01) -
Rho kinase inhibitors for glaucoma treatment - Review
by: Renato Antunes Schiave Germano, et al.
Published: (2015-12-01) -
Investigational Rho Kinase Inhibitors for the Treatment of Glaucoma
by: Al-Humimat G, et al.
Published: (2021-02-01) -
The Effect of Rho Kinase Inhibitors on Alzheimer's Disease
Published: (2017) -
An emerging treatment option for glaucoma: Rho kinase inhibitors
by: Wang SK, et al.
Published: (2014-05-01)